Literature DB >> 29419563

A Nonsurgical Approach to Mesenteric Vascular Disease.

Hossein Tabriziani, Armaghan Ahmad, Deepika Narasimha, Roberto Bergamaschi, William H Frishman.   

Abstract

Mesenteric ischemia is a rare disorder, with considerably high morbidity and mortality rates. It can manifest in several ways, including acute mesenteric ischemia, chronic mesenteric ischemia, nonocclusive mesenteric ischemia, mesenteric venous thrombosis, and colonic ischemia. Of these, acute mesenteric ischemia is the most severe form of intestinal ischemia, with a high mortality rate. The mainstay of therapy for mesenteric ischemia is surgical exploration and resection of infarcted bowel; however, medical therapy can play an important adjunctive role. When diagnosed early, before bowel infarction, endovascular therapy can be used as the primary treatment option. Endovascular therapy includes catheter-based thrombolysis, thromboembolectomy, and stenting. Vasodilators also play an important role in the early management of mesenteric ischemia. Anticoagulation is the main form of therapy in mesenteric venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29419563     DOI: 10.1097/CRD.0000000000000180

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  2 in total

1.  Mesenteric venous thrombosis in a pregnant woman at first trimester gestation: a case report.

Authors:  Rodrigo Piltcher-da-Silva; Vivian Laís Sasaki; João Francisco Petry; Guilherme Vieceli Rhoden; Matheus Antonio Chiconelli Zangari; Mariana Piltcher-Recuero; Gabriela de Melo Rocha; Paulo Cesar Andriguetto; Yan Sacha Aguilera; Júlio Cezar Uili Coelho
Journal:  J Surg Case Rep       Date:  2022-06-21

2.  Chronic mesenteric ischaemia masked by candida esophagitis in a renal transplant patient.

Authors:  Seth Scheetz; Deepali Pandey; Todd E Pesavento; Priyamvada Singh
Journal:  BMJ Case Rep       Date:  2019-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.